InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Saturday, 03/07/2020 11:11:09 AM

Saturday, March 07, 2020 11:11:09 AM

Post# of 6389
Runin, I seems to me PN is most excited about BP1003 the stat3 drug.

https://www.bostonbiomedical.com/science/targeting-cancer-cell-subsets/stat3-pathway/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610472/

He may be right but as usual where is the urgency? PN was urgent about putting 600,000 shares aside as potential compensation for him and the employees.

There has been work on stat3 drugs for years. No human trials yet for BPTH with less than 3 years of money left. Almost a year since they knew the results on last years poster. Too busy loading up their pockets?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News